Delivery Order SPE2DB20D2014-SPE2DB25FC42Y
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, an immunosuppressant medication, with a ceiling value of $8,462.05 and a period of performance through June 24, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 5 mg capsules (immediate-release). The contract is valued at $4,320.54 and has a period of performance through September 26, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is used to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $14,773.24 firm-fixed-price contract is for the delivery of Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has a period of performance through June 11, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of the medication Tacrolimus 5 mg (immediate-release) and has a ceiling value of $4,419.13. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 100 capsules of 1 mg Tacrolimus, an immunosuppressant drug used to prevent organ rejection. The contract has a potential value of $4,745.90 and a completion date of May 5, 2022. Amerisourcebergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.89, is for the delivery of 100 capsules of the medication Tacrolimus 5 mg. The contract has a performance period that extends through May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $22,833.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,767.09, is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used for various medical treatments. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Tacrolimus 1 mg capsules to support federal healthcare programs. It is a firm fixed-price delivery order valued at $1,242.74, with a period of performance through January 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ15H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $2,408.32 and was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC42YDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 1 mg capsules, an immunosuppressant medication. The delivery order has a ceiling value of $2,488.03 and a completion date of July 11, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/10/25 |